Last update:
Oncology news
Forcing cancer cells to die can alert the immune system to enhance anti-tumor attack
Unlike accidental cell death, some cells can actively decide to die through a controlled process. This is called programmed cell death and can occur in different forms, including apoptosis and necroptosis. Cells use this ...
8 minutes ago
0
0
AI tool improves prediction of who will respond to cancer immunotherapy drugs
Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work ...
3 hours ago
0
0
Are lung cancer tumors hijacking the nervous system?
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing ...
3 hours ago
0
0
New tumor map identifies high-risk B-cell lymphoma standard therapy may miss
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists ...
4 hours ago
0
0
Patients in Hawai'i spent $230M+ on out-of-state cancer care in 2021–2023, study finds
A new study led by researchers at the University of Hawaiʻi Cancer Center found that at least $230 million was spent on cancer care delivered outside Hawaiʻi between 2021 and 2023, highlighting the significant financial impact ...
5 hours ago
0
0
Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.
22 hours ago
0
4
Virus influences rare brain lymphomas, large study finds
Primary CNS lymphoma is a rare cancer that arises from malignant white blood cells. Affected individuals develop tumors in the brain and, more rarely, in the spinal cord, the eyes or within the cerebrospinal fluid. These ...
20 hours ago
0
2
Two prostate cancer mutations reveal opposite responses to ferroptosis therapy
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, ...
23 hours ago
0
4
Rural Americans more likely to view cancer as a death sentence, poll finds
People living in rural America are more likely to view cancer as a death sentence, a new survey reports. About 43% of people living in rural areas say a cancer diagnosis means inevitable death, compared to 35% of people in ...
17 hours ago
0
2
Risk-based strategies superior to US Preventive Services Task Force criteria for lung cancer screening
Risk-based strategies are superior to the U.S. Preventive Services Task Force (USPSTF) criteria for optimizing efficiency and minimizing variation of lung cancer screening across racial and ethnic groups, according to a study ...
19 hours ago
0
4
Preserved testicular tissue produces early germ cells after childhood cancer treatment
Researchers at Karolinska Institutet have demonstrated that it is possible to create early germ cells from preserved testicular tissue of young boys facing cancer therapy. The study, published in the journal Human Reproduction ...
20 hours ago
0
2
EHA: Adding Pirtobrutinib to Venetoclax-Rituximab ups progression-free survival in chronic lymphocytic leukemia
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according ...
22 hours ago
0
2
Long sitting bouts linked to increased cancer risk
Each additional hour of prolonged, uninterrupted sedentary behavior in a person's day is associated with a 9% higher risk of cancer death, according to a study published in PLOS Medicine by Frederick Ho of the University ...
Jul 2, 2026
0
14
Tumors hijack macrophages after they clear dead cells, real-time tracking reveals
Researchers at Tel Aviv University's Gray Faculty of Medical and Health Sciences have uncovered how a natural and essential immune system process can be hijacked to promote cancer progression. In a new study, the research ...
Jul 2, 2026
0
3
Cancer also knows how to wait: Study uncovers the hidden step between mutation and tumor biomass appearance
The development of cancer is not a process triggered immediately by the emergence of an oncogenic mutation. There is growing evidence for the existence of an intermediate phase—hitherto poorly defined—in which mutated cells ...
Jul 2, 2026
0
6
Using ultrasound to attack oral cancer cells
Oral cancer is a major health challenge in India, where tobacco and areca nut use contribute substantially to the disease burden. Despite advances in surgery, chemotherapy and radiotherapy, treatment remains difficult because ...
Jul 2, 2026
0
5
Going from the lab into the fire to study cancer risk in wildland firefighters
Cancer researchers at the Sylvester Firefighter Cancer Initiative (SFCI), part of the University of Miami Miller School of Medicine, took a rare step to better understand the cancer risks wildland firefighters face: They ...
Jul 2, 2026
0
4
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment ...
Jul 1, 2026
0
10
New immunotherapy strategy targets aggressive brain tumors and their immune cell accomplices
Researchers at McMaster University have developed a new cancer immunotherapy strategy that can simultaneously attack deadly brain tumors and the immune cells that help them grow.
Jul 1, 2026
0
10
A portable ultrasound system could make reliable breast imaging more accessible
For people at high risk of developing breast cancer, yearly mammograms may not be enough to detect tumors early. To make earlier diagnosis easier, an MIT team has developed portable detectors based on ultrasound, which could ...
Jul 1, 2026
0
7
CAR T cell therapy targets key mutation driving rare blood cancers
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells ...
Jul 1, 2026
0
5
TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies ...
Jul 1, 2026
0
4
Bacteria's 'mix-and-match' code could create new cancer-fighting drugs
A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies. The ...
Jul 1, 2026
0
7
Discovery could help prevent cancer drug resistance before it starts
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of California, Davis, shows how cancers adapt to evade a class of anti-tumor drugs called BET inhibitors and ...
Jul 1, 2026
0
5
Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals
Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer. The findings, which appear in the journal Nature, not ...
Jul 1, 2026
0
6
